Parallel Advisors’s Beam Therapeutics BEAM Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.65K | Sell |
97
-18
| -16% | -$306 | ﹤0.01% | 3059 |
|
2025
Q1 | $2.41K | Buy |
115
+15
| +15% | +$314 | ﹤0.01% | 2908 |
|
2024
Q4 | $2.48K | Buy |
100
+13
| +15% | +$322 | ﹤0.01% | 2873 |
|
2024
Q3 | $2.13K | Buy |
87
+1
| +1% | +$25 | ﹤0.01% | 2857 |
|
2024
Q2 | $2.02K | Hold |
86
| – | – | ﹤0.01% | 2793 |
|
2024
Q1 | $2.84K | Hold |
86
| – | – | ﹤0.01% | 2714 |
|
2023
Q4 | $2.34K | Sell |
86
-227
| -73% | -$6.18K | ﹤0.01% | 2754 |
|
2023
Q3 | $7.53K | Buy |
313
+300
| +2,308% | +$7.22K | ﹤0.01% | 2331 |
|
2023
Q2 | $415 | Sell |
13
-44
| -77% | -$1.41K | ﹤0.01% | 3135 |
|
2023
Q1 | $1.75K | Sell |
57
-376
| -87% | -$11.5K | ﹤0.01% | 2812 |
|
2022
Q4 | $16.9K | Buy |
433
+395
| +1,039% | +$15.4K | ﹤0.01% | 1783 |
|
2022
Q3 | $2K | Buy |
38
+14
| +58% | +$737 | ﹤0.01% | 2570 |
|
2022
Q2 | $1K | Sell |
24
-21
| -47% | -$875 | ﹤0.01% | 2686 |
|
2022
Q1 | $3K | Sell |
45
-62
| -58% | -$4.13K | ﹤0.01% | 2428 |
|
2021
Q4 | $9K | Buy |
107
+88
| +463% | +$7.4K | ﹤0.01% | 2132 |
|
2021
Q3 | $2K | Buy |
19
+9
| +90% | +$947 | ﹤0.01% | 2629 |
|
2021
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 2671 |
|
2021
Q1 | $1K | Hold |
10
| – | – | ﹤0.01% | 2562 |
|
2020
Q4 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 2378 |
|